H1: Physicians' Press - A Division of Jones and Bartlett Publishers: Authoritative, Expert, and User-Friendly References for the Medical Community

TOPICAL REVIEW

Cardiovascular Infections
Subacute bacterial endocarditis (p. 51)
Acute bacterial endocarditis (p. 53)
Prosthetic valve endocarditis (p. 55)
Pericarditis/myocarditis (p. 56)
IV line and pacemaker infections (p. 57)
Vascular graft infections (p. 60)

 

SELF-ASSESSMENT QUESTIONS: ENDOCARDITIS


1. Usual subacute bacterial endocarditis (SBE) pathogens include:

a. S. viridans

b. Enterococci (E. faecalis, E. faecium)

c. E. coli

d. Legionella, Coxiella burnetii, Chlamydia psittaci, Brucella

Make your selection before scrolling down beyond this point

Answer: Viridans streptococci from the mouth is responsible for 50-70% of all cases of native valve endocarditis in normal hosts. Usual endocarditis pathogens following GI and GU procedures are enterococci. Pathogens causing culture-negative endocarditis, which require specific serology for diagnosis, include Legionella, Coxiella burnetii, Chlamydia psittaci, and Brucella. E. coli is a common urinary tract pathogen, but is not a usual cause of SBE. (Answer: all except c)

2. Preferred IV treatment regimens for SBE include:

a. S. viridans: Ceftriaxone + gentamicin x 2 weeks

b. E. faecalis: Vancomycin + gentamicin x 2 weeks

c. E. faecium: Vancomycin + gentamicin x 4 weeks

d. S. bovis: Ceftriaxone + gentamicin x 2 weeks

Make your selection before scrolling down beyond this point

Answer: Preferred IV therapy for S. viridans SBE is a 2-week course of ceftriaxone 2 gm (IV) q24h plus gentamicin 120 mg (IV) q24h. For E. faecalis, therapy consists of vancomycin 1 g (IV) q12h plus gentamicin 80 mg (IV) q8h x 4-6 weeks, not 2 weeks. E. faecium (VRE) is resistant to vancomycin, and should be treated with linezolid 600 mg (IV) q12h x 4-6 weeks. S. bovis is treated the same as S. viridans SBE. (Answer: a, d)

3. In patients with S. viridans SBE:

a. Vegetations and fever without positive blood cultures or peripheral manifestations of SBE is adequate for the diagnosis

b. Vegetations may persist after antibiotic therapy, but are sterile

c. It is important to repeat blood cultures to document clinical
 responsiveness, even if the patient defervesces and appears to be responding clinically
d. A minimum of 4 weeks of antibiotic therapy is required

Make your selection before scrolling down beyond this point

Answer: S. viridans endocarditis presents as a subacute febrile illness " localizing symptoms/signs in a patient with a heart murmur. Peripheral manifestations (e.g., clubbing, splenomegaly, petechiae) are often absent with early diagnosis and treatment. Diagnosis is confirmed by positive blood cultures plus a cardiac vegetation on transthoracic or transesophageal echo; vegetations without positive blood cultures or peripheral manifestations of SBE are not diagnostic of endocarditis. Cardiac valve/mural vegetations may persist after antibiotic therapy, but are sterile. Weekly ESRs should be followed to monitor antibiotic response; repeat blood cultures are not required unless the patient has persistent fevers or is not responding clinically. A 2-week course of antibiotics is acceptable for uncomplicated S. viridans SBE. Prognosis is related to the extent of embolization and severity of heart failure, although cure rates generally exceed 90%. (Answer: b)

4. All of the following statements about SBE are true except:

a. S. bovis SBE is often associated with GI polyp or tumor

b. Enterococcal SBE commonly follows GI/GU instrumentation

c. Non-enterococcal Group D streptococci (S. bovis) is penicillin-sensitive, unlike Group D enterococci (E. faecalis)

d. Most cases of "culture-negative" SBE are not really culture negative, but are due to fastidious organisms requiring prolonged incubation with enhanced CO2 atmosphere for growth

Make your selection before scrolling down beyond this point

Answer: The most common SBE pathogens following GI/GU instrumentation are enterococci, especially E. faecalis. S. bovis is responsible for 10% of endocarditis cases, and is often associated with colonic polyps (65%) or malignancy (20%). S. bovis is sensitive to penicillin, unlike E. faecalis. Most cases of culture-negative SBE are not really culture negative, but are due to fastidious organisms (HACEK group), which require CO2/special media (Castaneda vented bottles) and prolonged incubation (2-4 weeks) for growth. (Answer: all are true)

 5. Usual acute bacterial endocarditis (ABE) and prosthetic valve endocarditis (PVE) pathogens include:

a. S. aureus for ABE in normal hosts

b. S. aureus and P. aeruginosa for ABE in IV drug abusers

c. S. viridans in early PVE

d. S. viridans and S. epidermidis in late PVE

Make your selection before scrolling down beyond this point

Answer: S. aureus is the most common cause of ABE (in normal hosts and IV drug abusers), and is the most common cause of early PVE (within 60 days of prosthetic valve replacement). S. aureus endocarditis is a severe infection (esp. in non-addicts), affects normal and abnormal valves, and is associated with multiple metastatic abscesses. S. viridans and S. epidermidis are common causes of late PVE. S. viridans is a common cause of SBE and late PVE, but not early PVE. (Answer: c)

6. Which of the following statements about acute bacterial endocarditis are true:

a. Methicillin-sensitive S. aureus (MSSA) endocarditis in normal hosts can be effectively treated with IV naficillin or meropenem or imipenem

b. ABE should be treated for 2-4 weeks in normal hosts and 4-6 weeks in IV drug abusers

c. Tricuspid valve endocarditis is more common in IV drug abusers than normal hosts, and is often associated with multiple septic emboli

d. Janeway lesions (nontender hemorrhagic lesions of the palms and soles), splenomegaly, and clubbing are more common in ABE than SBE

e. Teichoic acid antibody levels should be followed weekly in S. aureus ABE, and fall (along with the ESR) with effective therapy

f. Premature closure of the anterior mitral leaflet is an early sign of impending mitral valve regurgitation

Make your selection before scrolling down beyond this point

Answer: Patients with ABE are critically ill with high fever (except in some elderly patients or those with severe heart failure or renal failure) and cardiac vegetations. Due to the fulminant nature of ABE, a baseline echocardiogram should be obtained to watch for/identify valve destruction, heart failure, and ring/perivalvular abscesses; premature closure of the mitral valve leaflet signifies impending aortic valve regurgitation. Preferred IV therapy for ABE due to MSSA consists of a 4-6 weeks of nafcillin 2 gm (IV) q4h or meropenem 1 gm (IV) q8h or imipenem 1 gm (IV) q6h. ABE and PVE require a minimum of 4 weeks of antibiotic therapy. S. aureus ABE should be followed with weekly teichoic acid antibody levels, which fall along with the ESR with effective therapy. Janeway lesions (caused by septic embolic) are usually seen in ABE, whereas splenomegaly, clubbing of the fingers, and petechiae are more common in SBE. More than 70% of IV drug abusers with right-sided (tricuspid valve) endocarditis have associated septic pulmonary emboli mimicking pneumonia. Compared to S. aureus endocarditis in non-addicts, S. aureus endocarditis in IV drug abusers is usually less severe and associated with a better prognosis if not complicated by abscess, valve regurgitation, or heart failure. (Answer: a, c, e)

7. Which of the following statements about prosthetic valve endocarditis (PVE) are true:

a. Valve removal is always necessary for cure of early and late PVE

b. In late PVE, culture of the removed valve may be negative, but valve gram stain is usually positive

c. PVE is equally common after replacement of a non-infected or infected native valve

d. Most cases of late PVE occur 6-12 months post-operatively

e. The mortality rate for early PVE is higher than late PVE

Make your selection before scrolling down beyond this point

Answer: Patients with early PVE improve clinically on treatment, but are not cured without valve replacement. Valve removal may be necessary for late PVE due to S. epidermidis, but is not always required. Culture of the removed valve may be negative, but valve gram stain is usually positive. Late PVE usually presents 18-24 months after valve replacement, and occurs more commonly after replacement of an infected native valve than a non-infected valve (4% vs. 0.5% per patient-year), although not necessarily with the original pathogen. Early PVE resembles ABE, and is a more serious infection than late PVE, manifesting a more fulminant course and high mortality rates (~ 30%); late PVE resembles S. viridans SBE clinically. (Answer: b, e)

8. Endocarditis prophylaxis is:

a. Directed against S. viridans from the mouth for above-the-waist procedures

b. Directed against Enterococci for below-the-waist procedures

c. Fully protective is given properly

d. Preferred via the parenteral route for patients with previous endocarditis, shunts, or rheumatic valve disease

Make your selection before scrolling down beyond this point

Answer: Endocarditis prophylaxis is designed to prevent native/prosthetic cardiac valve infections by preventing procedure-related bacteremias due to cardiac pathogens. For procedures above-the-waist, usual pathogens are viridans streptococci from the mouth. For procedures below-the-waist, usual pathogens are enterococci. Since procedure-related bacteremias are usually asymptomatic and last less than 15 minutes, single-dose oral regimens prior to the procedure usually provide effective prophylaxis. Parenteral SBE prophylaxis is preferred for patients with previous endocarditis, shunts, or prosthetic heart valves. Regimens vary among the experts, and no regimen is fully protective. (Answer: a, b)

9. Which of the following patient-procedure combinations require endocarditis prophylaxis:

a. Patient with ostium primum atrial septal defect (ASD) undergoing Cesarean section

b. Patient with previous rheumatic fever without valve disease undergoing cholecystectomy

c. Patient with previous endocarditis undergoing flexible bronchoscopy with biopsy

d. Patient with MVP with valvular regurgitation undergoing urethral catheterization in the presence of a UTI

Make your selection before scrolling down beyond this point

Answer: Endocarditis prophylaxis is indicated for patients with cardiac conditions in Column A undergoing procedures in Column A in the table below. Prophylaxis is not recommended for patients or procedures in Column B. (Answer: d)

Table. Indications for Infective Endocarditis (IE) Prophylaxis

Subset

Prophylaxis Recommended
(Column A)

Prophylaxis Not Recommended
(Column B)

Cardiac conditions

Ostium primum ASD

Prosthetic heart valves, including bioprosthetic and homograft valves

Previous infective endocarditis

Most congenital cardiac malformations

Rheumatic valve disease

Hypertrophic cardiomyopathy

MVP with valvular regurgitation

Isolated ostium secundum ASD

Surgical repair without residue beyond 6 months of ostium secundum ASD or PDA

Previous coronary artery bypass surgery

MVP without valvular regurgitation

Physiologic, functional, or innocent murmurs

Previous Kawasaki's cardiac disease or rheumatic fever without valve disease

Procedures

Dental procedures known to induce gingival/mucosal bleeding, including dental cleaning

Tonsillectomy or adenoidectomy

Surgical operations involving intestinal or respiratory mucosa

Rigid bronchoscopy

Sclerotherapy for esophageal varices

Esophageal dilation

Gallbladder surgery

Cystoscopy or urethral dilation

Urethral catheterization or urinary tract surgery if UTI is present

Prostate surgery

I & D of infected tissue

Vaginal hysterectomy

Vaginal delivery, D & C, IUD insertion/removal, or therapeutic abortion in the presence of infection

Dental procedures not likely to induce gingival bleeding

Tympanostomy tube insertion

Flexible bronchoscopy with or without biopsy

Endotracheal intubation

Endoscopy " gastrointestinal biopsy

Cesarean section

D & C, IUD insertion/removal, or therapeutic abortion in the absence of infection

Cardiac pacemaker/defibrillator insertion

Coronary stent implantation

Percutaneous transluminal coronary angioplasty (PTCA)

Cardiac catheterization

 

10. Appropriate endocarditis prophylaxis regimens include:

a. Above-the-waist procedures: Amoxicillin 1 gm (PO) 1 hour preprocedure

b. Above-the-waist procedures, prior anaphylactic reaction to penicillin: Cephalexin 1 gm (PO) 1 hour preprocedure

c. Below-the-waist procedures: Amoxicillin 2 gm (PO) 1 hour preprocedure

d. Below-the-waist procedures, prior endocarditis: Amoxicillin 2 gm (PO) 1 hour preprocedure

Make your selection before scrolling down beyond this point

Answer: a, c (see Tables 1 and 2, below)

Table 1. Endocarditis Prophylaxis for Above-the-Waist (Dental, Oral, Esophageal, Respiratory Tract) Procedures*

Prophylaxis**

Reaction to Penicillin

Antibiotic Regimen

Oral prophylaxis

 

 

None

Amoxicillin 2 gm (PO) 1 hour pre-procedure+

Non-anaphylactoid

Cephalexin 1 gm (PO) 1 hour pre-procedure

Anaphylactoid

Clindamycin 300 mg (PO) 1 hour pre-procedure++

IV prophylaxis

 

 

None

Ampicillin 2 gm (IV) 30 minutes pre-procedure

Non-anaphylactoid

Cefazolin 1 gm (IV) 15 minutes pre-procedure

Anaphylactoid

Clindamycin 600 mg (IV) 30 minutes pre-procedure

*  Endocarditis prophylaxis is directed against Streptococcus viridans, the usual SBE pathogen above the waist. Macrolide regimens are less effective than other regimens; clarithromycin/azithromycin regimens (500 mg PO 1 hour pre-procedure) are of unproven efficacy
**  Oral prophylaxis is preferred to IV prophylaxis, except in patients with previous endocarditis, shunts, or prosthetic heart valves
+  Some recommend a 3 gm dose of amoxicillin, which is excessive given the sensitivity of viridans streptococci to amoxicillin
++  Some recommend a 600 mg dose of clindamycin, but a 300 mg dose gives adequate blood levels and is better tolerated (less diarrhea)

 

Table 2. Endocarditis Prophylaxis for Below-the-Waist (Genitourinary, Gastrointestinal) Procedures*

Prophylaxis**

Reaction to Penicillin

Antibiotic Regimen

Oral prophylaxis

 

None

Amoxicillin 2 gm (PO) 1 hour pre-procedure

Non-anaphylactoid, anaphylactoid

Linezolid 600 mg (PO) 1 hour pre-procedure

IV prophylaxis

 

None

Ampicillin 2 gm (IV) 30 minutes pre-procedure
                              plus
Gentamicin 80 mg (IM or IV) over 1 hour 60 minutes pre-procedure

Non-anaphylactoid, anaphylactoid

Vancomycin 1 gm (IV) over 1 hour 60 minutes pre-procedure
                             plus
Gentamicin 80 mg (IM or IV) over 1 hour 60 minutes pre-procedure

*  Endocarditis prophylaxis is directed against Enterococcus faecalis, the usual SBE pathogen below the waist
**  Oral prophylaxis is preferred to IV prophylaxis, except in patients with previous endocarditis, shunts, or prosthetic heart valves

 

ENDOCARDITIS PITFALLS

PITFALL: USE OF CONVENTIONAL DOSES OF BETA-LACTAMS FOR
STREP VIRIDANS SBE

Due to the extreme sensitivity of viridans streptococci to beta-lactams, some clinicians use conventional doses of beta-lactams (e.g. penicillin G) to treat S. viridans SBE. Nevertheless, high (endocarditis) doses of antibiotics (e.g., penicillin G 2-4 million units IV q4h) are recommended to penetrate cardiac vegetations and ensure organisms under the fibrin blanket of the vegetation are eradicated.

PITFALL:   EXCESSIVE DOSING OF GENTAMICIN FOR STREP VIRIDANS SBE

Synergy between gentamicin and beta-lactams is useful to decrease treatment duration without increasing relapse rates, but is no more effective at eradicating S. viridans SBE than treatment with a beta-lactam alone for 4 weeks. Two weeks of beta-lactam monotherapy is as efficacious as 4 weeks of therapy, but is associated with a higher relapse rate and is therefore not recommended. When used for synergy, the dose of aminoglycosides in less (usually ~ ½) than the usual monotherapy dose. Gentamicin has no action against streptococci when used alone.

PITFALL:   USE OF VANCOMYCIN ALONE FOR ENTEROCOCCAL ENDOCARDITIS IN PENICILLIN-ALLERGIC PATIENTS

Bactericidal antibiotics are preferred for the treatment of endocarditis. For penicillin-tolerant patients, the usual treatment of enterococcol (E. faecalis) endocarditis is ampicillin plus gentamicin. For penicillin-allergic patients, vancomycin alone is inadequate, since it is bacteriostatic (not bactericidal) against E. faecalis. Vancomycin is, however, highly effective when combined with gentamicin. Alternatively, linezolid, imipenem, or meropenem could be used to treat E. faecalis SBE in penicillin-allergic patients.

 

ARCHIVES

The  other archives can be reached by returning to the Antibiotic Self-Assessment page and clicking on the individual links there.

 

Link: Jones and Bartlett Publishers© 2009 Jones and Bartlett Publishers